[Improved stroke prevention in atrial fibrillation: the Stockholm experience of the introduction of NOACs] [0.03%]
[改善房颤卒中的预防:斯德哥尔摩对NOACs引进的经验]
Paul Hjemdahl,Frieder Braunschweig,Margareta Holmström et al.
Paul Hjemdahl et al.
The introduction of NOACs has put a focus on stroke prevention in atrial fibrillation (AF). The number of patients in Stockholm diagnosed with non-valvular AF increased from 41 008 in 2011 to 51 266 in 2017 and their treatment has been mark...
Review
Lakartidningen. 2018 Oct 26:115:FAH6. DOI: 2018
Alexandra Horvath,Olof Westin,Kristian Samuelsson et al.
Alexandra Horvath et al.
Ola Bratt
Ola Bratt
The current praxis of diagnosing prostate cancer, with systematic prostate biopsies in men with raised serum prostate-specific antigen (PSA) levels, leads to considerable over-diagnosis and over-treatment of indolent cancer. Recent research...
Comment
Lakartidningen. 2018 Oct 23:115:FCFW. DOI: 2018
[Improved prostate cancer diagnostics with a struc-tured pathway including the Stockholm3 test and MRI--targeted biopsies - experiences from Capio S:t Göran Prostate Cancer Center] [0.03%]
采用斯德哥尔摩3检查和MRI-靶向活检的前列腺癌诊断的结构路径优化——卡皮奥圣戈朗前列腺中心的经验总结
Martin Bergman,Marie Hjälm Ericsson,Fredrik Jäderling et al.
Martin Bergman et al.
Capio S:t Göran Prostate Cancer Center is located in Stockholm and offers testing for prostate cancer using a structured pathway including the blood-test Stockholm3 and MRI-targeted prostate biopsies. The diagnostic pathway is organized by...
Anna Bergström,Ola Rollman,Lennart Emtestam et al.
Anna Bergström et al.
Mastocytosis is a rare and multifaceted disease group characterized by mast cell accumulation in the skin and/or internal organs. In its most common form solitary or widespread, often itchy, red-brown skin lesions appear in childhood or dur...
Review
Lakartidningen. 2018 Oct 22:115:FASY. DOI: 2018
Anders C Håkansson
Anders C Håkansson
Karin Hyland
Karin Hyland
Felicia Ahlner,Ingmar Skoog,Margda Waern
Felicia Ahlner
[Riskstratification in pulmonary arterial hypertension - renders better treatment and prognosis at highly specialised centers] [0.03%]
[肺动脉高压的风险分层在高水平的专业中心进行能更好地指导治疗和预后]
Göran Rådegran
Göran Rådegran
Pulmonary arterial hypertension (PAH) is a progressive vascular disease, due to vasoconstriction and remodelling of pulmonary arteries. Survival has from diagnosis, if untreated, been found to be 1 to 2.8 years, depending on whether related...